Cargando…

Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B

Female gender and younger age are protective factors against disease progression in chronic hepatitis B (CHB). However, it is not clear whether the disease progression still remains slow in elderly females. This study investigated the interaction of female gender and older age on the development of...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Hong, Kong, Yuanyuan, Hou, Jinlin, Wei, Lai, Zhang, Yuexin, Niu, Junqi, Han, Tao, Ou, Xiaojuan, Dou, Xiaoguang, Shang, Jia, Tang, Hong, Xie, Qing, Ding, Huiguo, Ren, Hong, Xu, Xiaoyuan, Xie, Wen, Liu, Xiaoqing, Xu, Youqing, Li, Yujie, Li, Jie, Chow, Shein-Chung, Zhuang, Hui, Jia, Jidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124962/ https://www.ncbi.nlm.nih.gov/pubmed/27892487 http://dx.doi.org/10.1038/srep37498

Ejemplares similares

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
por: Wu, Xiaoning, et al.
Publicado: (2019)

Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B
por: Cheng, Jieyao, et al.
Publicado: (2015)

Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis B
por: Shan, Shan, et al.
Publicado: (2019)

Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients
por: Wu, Xiaoning, et al.
Publicado: (2023)

The Impact of the Definitions of Clinical Phases on the Profiles of Grey-Zone Patients with Chronic Hepatitis B Virus Infection
por: Xu, Xiaoqian, et al.
Publicado: (2023)

The CYP2E1 inhibitor DDC up-regulates MMP-1 expression in hepatic stellate cells via an ERK1/2- and Akt-dependent mechanism
por: Liu, Tianhui, et al.
Publicado: (2013)

Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
por: You, Hong, et al.
Publicado: (2023)

Changing clinical care cascade of patients with chronic hepatitis B in Beijing, China
por: Li, Min, et al.
Publicado: (2021)

Control of Chronic Hepatitis B in China: Perspective of Diagnosis and Treatment
por: Wang, Yu, et al.
Publicado: (2020)

Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis
por: Zhang, Qian, et al.
Publicado: (2019)

A recurrent ABCC2 p.G693R mutation resulting in loss of function of MRP2 and hyperbilirubinemia in Dubin-Johnson syndrome in China
por: Wu, Lina, et al.
Publicado: (2020)

Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up
por: Zhang, Wei, et al.
Publicado: (2017)

HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case
por: Zhang, Wei, et al.
Publicado: (2020)

Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak “stable” patients on anti-HBV therapy
por: Sun, Yameng, et al.
Publicado: (2018)

Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets
por: Li, Hai, et al.
Publicado: (2016)

The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti‐mitochondrial antibodies but without baseline PBC
por: Duan, Weijia, et al.
Publicado: (2022)

Insertion of LINE-1 Retrotransposon Inducing Exon Inversion Causes a Rotor Syndrome Phenotype
por: Zhou, Donghu, et al.
Publicado: (2020)

A multimodal international collaborative clinical research training program in China
por: Zhang, Qian, et al.
Publicado: (2019)

Clinical characteristics and therapeutic response of immunoglobulin G4-related disease: a retrospective study of 127 Chinese patients
por: An, Wen, et al.
Publicado: (2022)

Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection
por: Rao, Huiying, et al.
Publicado: (2014)

Dacomitinib in lung cancer: a “lost generation” EGFR tyrosine-kinase inhibitor from a bygone era?
por: Ou, Sai-Hong Ignatius, et al.
Publicado: (2015)

A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a
por: Chen, Xinyue, et al.
Publicado: (2019)

Tenofovir disoproxil fumarate for multiple nucleos(t)ide analogues treatment failure hepatitis B: Is monotherapy enough?
por: Liang, Xieer, et al.
Publicado: (2022)

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues
por: Fan, Rong, et al.
Publicado: (2016)

Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)
por: You, Hong, et al.
Publicado: (2023)

Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update)
por: Hou, Jinlin, et al.
Publicado: (2017)

HBeAg-positive patients with HBsAg < 100 IU/mL and negative HBV RNA have lower risk of virological relapse after nucleos(t)ide analogues cessation
por: Xie, Yandi, et al.
Publicado: (2021)

Consensus on the tertiary prevention of primary liver cancer
por: Nan, Yuemin, et al.
Publicado: (2023)

Laparoscopic management of pedicle torsion of adnexal cysts
por: WANG, YUXIA, et al.
Publicado: (2013)

A Meta-Analysis of the Efficacy of Interferon Monotherapy or Combined with Different Nucleos(t)ide Analogues for Chronic Hepatitis B
por: Zhou, Jialing, et al.
Publicado: (2016)

Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation
por: Xie, Yandi, et al.
Publicado: (2023)

Correction to: Consensus on the secondary prevention of primary liver cancer
por: Nan, Yuemin, et al.
Publicado: (2022)

Consensus on the secondary prevention of primary liver cancer
por: Nan, Yuemin, et al.
Publicado: (2021)

Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results
por: Liang, Xieer, et al.
Publicado: (2019)

Mass brain tissue lost after decompressive craniectomy: A case report
por: Li, Guang-Gang, et al.
Publicado: (2022)

Management Algorithm for Prevention of Mother-to-child Transmission of Hepatitis B Virus (2022)
por: Liu, Zhihua, et al.
Publicado: (2022)

SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies
por: Wang, Bingqiong, et al.
Publicado: (2019)

Quantitative Methods for Traditional Chinese Medicine Development
por: Chow, Shein-Chung
Publicado: (2015)

Reassessing the importance of ‘lost pleasure’ associated with smoking cessation: implications for social welfare and policy
por: Pechacek, Terry Frank, et al.
Publicado: (2018)

Identification of potential modifier genes in Chinese patients with Wilson disease
por: Zhou, Donghu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cst9jd07e8vfp2cl0119a0kkbf